Evaluation of nested and real-time PCR assays in the diagnosis of candidaemia  by Khlif, M. et al.
Evaluation of nested and real-time PCR assays in the diagnosis of
candidaemia
M. Khlif1, C. Mary2, H. Sellami1, A. Sellami1, H. Dumon2, A. Ayadi1 and S. Ranque2
1) Laboratoire de Biologie Mole´culaire Parasitaire et Fongique, Faculte´ de Me´decine, University of Sfax, Sfax, Tunisia and 2) Laboratoire de Parasitologie-My-
cologie, Hoˆpital de la Timone, Marseille, France
Abstract
Polymerase chain reaction (PCR) assays have a very low theoretical detection threshold and are therefore advocated for the diagnosis
of fungaemia. However, their effectiveness in this respect remains to be assessed. This study compared real-time PCR (Can-G) and
nested PCR assays with blood culture for the diagnosis of Candida spp. bloodstream infections. A total of 200 clinical blood samples
obtained from 110 patients at risk for developing a systemic fungal infection, hospitalized in the University Hospital of Sfax (Tunisia),
were submitted to testing by culture, nested PCR and real-time PCR. Blood culture was positive in 36 patients. When compared with
culture, the Can-G assay (81% sensitivity, 96% speciﬁcity) performed better than the nested PCR assay (86% sensitivity, 54% speciﬁcity).
The real-time PCR assay, which avoids both the contamination hazard with amplicons that may cause false-positive results and the use
of time-consuming post-PCR steps, appears more suitable than the nested PCR assay for the laboratory diagnosis of Candida spp. blood-
stream infections. In this study, real-time PCR did not enhance the diagnostic sensitivity for Candida spp. bloodstream infections com-
pared with conventional blood culture; however, it may lead to earlier implementation of an adequately targeted antifungal treatment.
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Introduction
Blood culture systems, the reference standard for diagnosis
of fungal bloodstream infections, have provided negative
results in many proven cases of invasive candidiasis. For
instance, in patients with autopsy-veriﬁed invasive candidiasis,
fungal infection had been suspected or conﬁrmed antemor-
tem in only 8–32% of cases [1]. The development of speciﬁc
and sensitive diagnostic tests for early detection of yeast
DNA in blood should overcome the limitations of traditional,
culture-based fungal detection methods. PCR ampliﬁcation
and hybridization with species-speciﬁc probes [2,3] or other
methods to identify unique DNA sequences [4] have been
reported to be useful in detecting and identifying fungal spe-
cies. More recently, various real-time PCR assays have dem-
onstrated comparable or better sensitivity for the detection
of fungal pathogens. In real-time PCR assays, the PCR and
detection systems are coupled; the absence of post-PCR
steps limits the risk of amplicon contamination. Guiver et al.
[5] described several exonuclease-based TaqMan PCR assays
capable of rapid identiﬁcation and speciation of six Candida
species. White et al. [6], using the LightCycler system,
detected seven Candida species.
This study aimed to compare real-time PCR and nested
PCR assays with blood culture for the diagnosis of Candida
spp. bloodstream infections. A secondary aim was to compare
an additional real-time PCR assay with both nested PCR and
the conventional culture-based phenotypic method for the
identiﬁcation of Candida species isolated from blood cultures.
Materials and Methods
Clinical samples were obtained from patients hospitalized
in Sfax University Hospital, Tunisia, who presented with the
following criteria: persistent fever despite broad-spectrum
antibacterial therapy; isolation of Candida from blood or
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other sterile sites, and colonization of multiple sites with
Candida spp. All samples were evaluated by means of blood
culture, nested PCR and real-time PCR. Approximately
10 mL of fresh blood obtained from patients was inoculated
aseptically into a blood culture bottle containing 50 mL of
Sabouraud liquid medium (Pronadisa SA, Madrid, Spain) and
incubated at 37 C for 14 days maximum. DNA was
extracted directly from 200 lL of blood + culture medium
sampled from the culture bottles at the time of their arrival
at the laboratory, prior to incubation. Phenotypic identiﬁca-
tion of yeasts was based on germ tube assessment and car-
bohydrate assimilation proﬁles on ID 32 C (bioMe´rieux SA,
Marcy-l’Etoile, France). Chlamydospore formation on RAT
medium and CHROM Agar Candida (Becton Dickinson
France SAS, Le Pont-De-Claix, France) were used when nec-
essary. Phenol-chloroform DNA extraction and nested PCR
procedures were performed as detailed elsewhere [7]. DNA
extraction, mix assembly and the incorporation of DNA
template into the mix were performed in separate rooms.
The clinical specimens were tested using two real-time
PCR assays: a Candida genus-speciﬁc real-time PCR, referred
to as the Can-G assay, and a Candida species-speciﬁc real-
time PCR assay, referred to as the Can-S assay. The ampliﬁed
PCR products were identiﬁed with various ﬂuorescent
probes based on TaqMan chemistry (Applied Biosystems,
Inc., Warrington, UK). All samples were tested with the
Can-G assay; only those positive according to culture and/or
the Can-G assay were tested with the Can-S assay.
Genus-speciﬁc real-time PCR
The Can-G real-time PCR assay targeted the 18S rRNA gene
of the genus Candida. In this group, one set of primers and
two probes were used (Table 1): Can, labelled with VIC ﬂuo-
rochrome, hybridizes Candida albicans, Candida parapsilosis
and Candida tropicalis; Ckg, labelled with FAM ﬂuorochrome,
hybridizes Candida krusei and Candida glabrata.
Species-speciﬁc real-time PCR
The second real-time PCR assay, referred to as Can-S,
targeted internal transcribed spacer 1 (ITS1), 5.8S, ITS2 in
the rDNA (the same as nested PCR) with TaqMan
probes designed to detect ﬁve species: C. albicans, C. krusei,
C. glabrata, C. tropicalis and C. parapsilosis.
PCR conditions
The samples were analysed using the Mx 4000 real-time
PCR machine (Stratagene Corp., La Jolla, CA, USA). Each
25 lL of the PCR mixture consisted of a 2 lL aliquot of
sample DNA, 1· PCR buffer, 3.5 mM MgCl2, 0.2 lM of each
primer, deoxyribonucleoside triphosphate at a concentration
of 0.2 mM, 0.2 lM of each speciﬁc probe, 2 U of Taq DNA
polymerase (Stratagene Corp.), and 0.5 lL of 6-carboxy-
x-rhodamine (ROX) passive reference dye (Stratagene Corp.).
Thermal cycling conditions consisted of denaturation at
95 C for 10 min, followed by 45 cycles of 30 s at 95 C
and 1 min at 54 C. A positive reaction was characterized by
the number of cycles (CT) at which the baseline ﬂuorescence
threshold was exceeded. Both VIC and FAM-labelled probes
were used in combination in each Can-G PCR run. In the
Can-S assay, VIC and FAM probes were used in combination
(C. albicans + C. tropicalis; C. glabrata + C. parapsilosis); the
C. krusei probe was used singly.
Real-time PCR analytical sensitivity
Blood from healthy volunteers spiked with C. albicans cells
was used to determine the fungal DNA detection threshold
in the presence of human DNA. The extracted DNA was
serially diluted over a range of 104–10 C. albicans CFU. The
theoretical detection threshold (number of genome equiva-
lent/reaction tube) and the clinical detection threshold (num-
ber of CFU/mL of blood) were calculated.
Statistical analysis
The following indices of diagnostic performance, and their
95% conﬁdence intervals (CIs), were computed for each
assay: sensitivity (Se); speciﬁcity (Sp); likelihood ratio (LR)
test positive (LR+); LR test negative (LR)), and Yule Q coefﬁ-
cient. For sensitivity and speciﬁcity, LR+ and LR) are inde-
pendent of prevalence, by contrast with predictive values.
The LR for a positive test result (LR+) is calculated as
Se/(1)Sp). The LR for a negative test result (LR)) is calcu-
lated as (1)Se)/Sp. The Yule Q coefﬁcient measures the
strength of the association between the test results and the
TABLE 1. Sequences of primers and probes used in
real-time PCR assays
Primers (F)
forward; (R) reverse
and probes Nucleotide sequences (5¢–3¢) bp
Can-G Fungi F AAGCTCGTAGTTGAACCTTG 20
Fungi R ATGGTCCTAGAAACCAACAA 20
Can probe VIC-ACCGAGCCTTTCCTTCTGGC 20
Ckg probe FAM-CCGGGTCTTTCCTTCTGGCT 20
Can-S Can 1Fa GAACCTGCGGAAGGATCA 18
Can 1Rb ATTTCGCTGCGTTCTTCAT 19
Can 2F (glabrata) GTAGGTGAACCTGCGGAAG 19
Can 2R (glabrata) ACTTAAGCGCAGGCAGGA 18
Can 3R (krusei) TGGCTGCAATTCACACTAGG 20
C. albicans, probe VIC-AACTTGCTTTGGCGGTGGGC 20
C. tropicalis, probe FAM-TGGCGGGAGCAATCCTACCA 20
C. glabrata, probe VIC-TCGGAGAGAGACATCTCTGGGGA 23
C. parapsilosis, probe FAM-CTTTGCTTTGGTGGGCCCAC 20
C. krusei, probe FAM-CACTGCGTGAGCGGAACGAA 20
aCan 1F: primer that ampliﬁes Candida albicans, Candida tropicalis, Candida
parapsilosis and Candida krusei.
bCan 1R: primer that ampliﬁes C. albicans, C. tropicalis, C. parapsilosis.
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disease. Cohen’s kappa estimates the accuracy of the test
beyond the agreement by change.
Results
Samples were obtained from 110 patients at risk of develop-
ing a systemic fungal infection who were hospitalized in Sfax
University Hospital, Tunisia. Of these patients, 51 were hos-
pitalized in the intensive care unit (ICU) (in a context of
abdominal surgery, respiratory failure, trauma, etc.) and the
remaining patients were treated on the following wards: hae-
matology (n = 16); neonatology (n = 24); infectious diseases
(n = 8); burns (n = 4); oncology (n = 4); urology (n = 2), and
endocrinology (n = 1). During the study period, a total of
200 clinical blood culture specimens were analysed. In 36
specimens the culture was positive. Thirty of these were
identiﬁed as follows: C. albicans (n = 11); C. tropicalis (n = 8);
C. glabrata (n = 5); C. parapsilosis (n = 3); C. krusei (n = 1);
Pichia ohmeri (n = 1), and C. guillermondii (n = 1). Three cases
of mixed Candida infection were identiﬁed (C. albi-
cans + C. parapsilosis, n = 1; C. albicans + C. glabrata, n = 2)
and three other yeasts could not be phenotypically identiﬁed.
Nested PCR was positive in 65 samples and correctly
detected and identiﬁed three cases of culture-conﬁrmed
mixed Candida infection with C. glabrata + C. albicans (n = 2)
and C. albicans + C. parapsilosis (n = 1). Five cases of positive
blood culture were not detected and identiﬁed by the nested
PCR assay, including: C. guillermondii (n = 1); P. ohmeri
(n = 1), and the three yeasts that could not be identiﬁed by
phenotypic methods. The nested PCR assay was positive
in 34 blood culture-negative patients (31%). Its diagnostic
indices are detailed in Table 2.
The Can-G real-time PCR assay analytical detection
threshold was 0.1 C. albicans equivalent genome per reaction
tube. Thus, the calculated clinical detection threshold was
100 CFU/mL of blood. As Table 2 shows, the Can-G assay
was positive in 29 of 36 cases of positive blood culture.
Twenty-ﬁve reactions were positive using the Can probe, 11
using the Ckg probe, and 10 specimens hybridized with both
probes. This assay was positive in the sample in which C. guil-
lermondii had been cultivated and in two of the three samples
in which phenotypically unidentiﬁed yeasts were grown.
When compared with blood culture (Table 2), the Can-G
had slightly better diagnostic indices than the nested PCR. A
kappa value of 0.30 (95% CI 0.13–0.46) indicates a fair con-
cordance between the Can-G and nested PCR assays.
The Can-S assay correctly identiﬁed 26 of 28 patients with
a positive blood culture caused by a single Candida sp. infec-
tion (Table 3). This assay also correctly identiﬁed two cases of
mixed infection caused by C. glabrata and C. albicans. The third
case was identiﬁed by this assay as a C. parapsilosis infection.
The Can-S did not detect the case of a positive blood culture
caused by P. ohmeri, or two other cases of phenotypically
unidentiﬁed yeasts. Candida guillermondii annealed to three
different probes: C. albicans, C. tropicalis and C. glabrata. The
C. albicans probe annealed to one of the three phenotypically
unidentiﬁed yeasts. Two phenotypically identiﬁed C. tropicalis
isolates were identiﬁed as C. albicans with both nested PCR
and Can-S real-time PCR assay (Table 3).
Discussion
Although several PCR assays have been developed for the
diagnosis of invasive candidiasis, this is the ﬁrst study to
compare the efﬁciency of nested PCR and real-time PCR for
the diagnosis of candidaemia in patients at high-risk for fungal
bloodstream infection. Molecular diagnosis was directly per-
formed from blood culture bottles obtained from these
patients. The diversity of sample volume, extraction meth-
ods, ampliﬁcation protocols and primer selection, together
with the range of source material studied, prevents direct
comparison with published data.
Blood culture samples are available in most clinical labora-
tories and provide the opportunity to perform a molecular
diagnosis in addition to culture. However, some authors
have used whole blood samples for the detection and identi-
ﬁcation of Candida spp. in the diagnosis of candidaemia
[8–11]. Others have reported that serum is the most
convenient sample for the diagnosis of candidaemia [12–14].
To date, the optimal biological specimen for the molecular
detection of invasive candidiasis is a matter of debate. A
particularity of the present study was that the patient blood
was sampled, as recommended for haemoculture, during
bouts of fever and/or chills. This might enhance the PCR
TABLE 2. Comparison of nested PCR or real-time PCR with
blood culture for the diagnosis of candidaemia in 110 patients
Culture
Nested PCR
Can-G
real-time PCR
+ ) + )
+ 31 5 29 7
) 34 40 3 71
Total 65 45 32 78
Sensitivity 86% 81%
Speciﬁcity 54% 96%
Likelihood ratio + 1.87 19.87
Likelihood ratio ) 0.26 0.20
Yule Q 0.76 0.98
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sensitivity because the amount of circulating yeast DNA is
probably higher in the presence rather than the absence of
fever.
Fungal DNA extraction from a clinical sample is a critical
step for molecular diagnosis. In the present study, DNA was
extracted from blood culture samples by an enzymatic diges-
tion method, using salts and detergents, according to many
studies that describe a process for direct recovery of fungal
DNA from blood [8,15,16]. Most processes require initial
lysis with salts, detergents and proteinase K, and multiple
puriﬁcation steps and pre-extraction enzymatic treatments
may enhance PCR analytical sensitivity [17,18].
Lack of standardization is a major concern in the context
of molecular diagnosis of invasive fungal infections. Table 4
summarizes the various PCR assays that have been used for
the diagnosis of candidaemia and highlights some of the
methodological discrepancies that complicate direct compari-
son among these studies [12,19–25]. The real-time PCR
assay Can-G targets the 18S region of the rDNA of at least
the ﬁve major Candida species involved in human pathology.
The 18S rRNA genes have been extensively used for the
molecular detection and identiﬁcation of fungi [8,10,11]. The
species-speciﬁc nested PCR and Can-S real-time PCR assay
target speciﬁc sequences in the ITS1, 5.8S and ITS2 regions
of the rDNA of the ﬁve major Candida species. The ITS are
less conserved than the rDNA genes, and their polymor-
phisms allow discrimination of species within the Candida
genus [2,26].
The nested PCR assay was positive in 65 (59%) patients
who were at risk of developing invasive candidiasis. Nested
PCR has the advantages of speciﬁc species identiﬁcation and
a very high sensitivity, with a detection limit of one genome
equivalent/mL serum. However, it can only detect ﬁve Can-
dida species and it requires two PCR runs and post-ampliﬁca-
tion steps, which are time-consuming and are a recognized
source of false-positive results.
We would stress, however, that probably only a rather
small number of the 31% of patients for whom culture results
were negative and nested PCR results were positive represent
true false-positive results caused by PCR contamination.
We believe that, given its high sensitivity, the nested PCR
allows for the detection of very small (and possibly clinically
irrelevant) amounts of Candida DNA in the blood. It should
also be noted that the inexpensive blood culture system
used in this study may have a lower sensitivity than widely
used automated culture systems and may thus preferentially
inﬂate the false-positive rate. The Can-G real-time PCR
TABLE 3. Detection and identiﬁcation of yeast in positive blood cultures. Comparison of nested PCR, genus-speciﬁc real-time
PCR (Can-G) and species-speciﬁc real-time PCR (Can-S) assays
Candida spp. C. albicans C. tropicalis C. glabrata C. parapsilosis C. krusei
Blood culture Can-G N PCR Can-S N PCR Can-S N PCR Can-S N PCR Can-S N PCR Can-S
C. albicans (n = 11) 9 11 10 – – – – – – – –
C. tropicalis (n = 8) 7 2 2 6 6 – 1a – – – –
C. glabrata (n = 5) 5 – – – – 5 5 – – – –
C. parapsilosis (n = 3) 2 – – – – – – 3 2 – –
C. krusei (n = 1) 1 – – – – – – – – 1 1
C. albicans + C. parapsilosis (n = 1) 0 1 – – – – – 1 1 – –
C. albicans + C. glabrata (n = 2) 2 2 2 – – 2 2 – – – –
Pichia ohmeri (n = 1) 0 – – – – – – – – – –
C. guillermondii (n = 1) 1 – 1 – 1 – 1 – – – –
Unidentiﬁed yeast (n = 3) 2 – 1 – – – – – – – –
aOne sample identiﬁed as C. tropicalis was positive with both C. tropicalis and C. glabrata probes in the Can-S real-time PCR assay.
TABLE 4. Sensitivity and speciﬁcity of various molecular
assays and other associated techniques for the diagnosis of
candidaemia
Technique Comparator
Sensitivity
(%)
Speciﬁcity
(%) Reference
LC PCR 95 97 White et al. [25]
ELISA 75 97
UELA 25 100
PCR/Seq BC 72 91 Moreira-
Olivera et al. [24]
Sn PCR BC 88 – Alam et al. [19]
BDG 47 –
Mannan 41 –
AMA 47 –
TaqMan BC 100 97 Maarouﬁ et al. [23]
Ag
detection
100 86
Nested PCR
(serum)
BC 93 – Bougnoux et al. [12]
(whole blood) 86 –
Multiplex PCR BC 98 88 Chang et al. [21]
Nested PCR BC 79 – Kan [22]
PCR ELISA BC 83 92 Badiee et al. [20]
Nested PCR BC 86 54 This study
TaqMan 81 96
LC, light cycler; ELISA, enzyme-linked immunosorbent assay; UELA, latex aggluti-
nation; BC, blood culture; PCR/Seq, PCR sequencing; Sn PCR, semi-nested PCR;
BDG, (1,3)-b-D-glucan; Ag detection, antigen detection; Mannan, detection of
Candida mannan Ag; AMA, anti-mannan antibodies.
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detected yeasts of the genus Candida in 32 (29%) patients at
risk of developing invasive candidiasis.
The Can-S assay identiﬁed the species of 28 of the positive
specimens detected by Can-G. It correctly identiﬁed mixed
infection with C. albicans and C. glabrata, but did not detect
C. albicans in a mixed C. albicans + C. parapsilosis infection
documented by both nested PCR and culture. The species-
speciﬁc probes designed in this study detected Candida spp.
DNA from 28 patients with a positive blood culture and
gave no false-positive results when compared with the refer-
ence standard, blood culture. However, two samples that
were positive according to nested PCR and culture were
negative according to Can-S assay. A lack of speciﬁcity of the
Can-S assays for species identiﬁcation is the most probable
explanation for the detection of C. guillermondii with three
different probes, of C. tropicalis with the C. glabrata probe
and of one of the three phenotypically unidentiﬁed yeasts
with the C. albicans probe, all of which were negative accord-
ing to nested PCR (Table 3). Negative PCR in ultimately cul-
ture-positive samples represents a serious problem in making
a diagnosis. Deﬁcient DNA extraction, small amounts of tar-
get DNA in the sample, as well as the small amount of sam-
ple submitted to PCR, or PCR inhibitors, may explain such
false-negative results.
Differentiating between clinically relevant Candida species is
of great value in guiding antifungal therapy [27,28]. Van Burik
et al. and White et al. described panfungal PCR assays that can
only detect the genus Candida [6,29,30]. Pryce et al. described
a Light Cycler assay for the diagnosis of invasive fungal infec-
tion using probes speciﬁc for Aspergillus fumigatus or C. albi-
cans, but unable to detect the other species [31]. Recently,
Schabereiter-Gurtner et al. [32] described a Light Cycler assay
that allows the simultaneous detection and identiﬁcation of
various Candida and Aspergillus species; its clinical efﬁciency
needs to be assessed in prospective studies.
In conclusion, real-time PCR appears to be more speciﬁc
than nested PCR for the detection of medically important Can-
dida species in blood culture samples. Real-time PCR may be
more suitable for laboratory diagnosis than nested PCR as it is
at least twice as fast as nested PCR and avoids both the hazard
of contamination with amplicons and the use of gel electro-
phoresis. PCR signiﬁcantly reduces the time required to iden-
tify the Candida species obtained from blood culture bottles
and should facilitate a more rapid and speciﬁc diagnosis, which
would lead to the earlier implementation of an adequate anti-
fungal treatment. However, in this study, real-time PCR did
not signiﬁcantly enhance the sensitivity of the diagnosis of can-
didaemia compared with conventional blood culture. Further
studies are needed to increase the sensitivity of real-time PCR
assays for the diagnosis of candidaemia.
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